W. ten Bokkel Huinink

Long-term survival in a phase III, randomised study of topotecan versus paclitaxel in advanced epithelial ovarian carcinoma

W. ten Bokkel Huinink, Stephen Lane, G. Ross · Annals of Oncology · 2003 · 130 citations · Full text

Medicine, Gynecology, Oncology +13

Docetaxel: an Active New Drug for Treatment of Advanced Epithelial Ovarian Cancer

Martine Piccart, Martin Gore, W. ten Bokkel Huinink et al. · JNCI Journal of the National Cancer Institute · 1995 · 128 citations

Medicine, Oncology, Pharmacology +16

Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group

R. de Wit, G. Stoter, Dirk Th. Sleijfer et al. · British Journal of Cancer · 1995 · 99 citations

Medicine, Oncology, Genitourinary Oncology +6

Serum alpha-fetoprotein surge after the initiation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significance

Ronald de Wit, Laurence Collette, Richard Sylvester et al. · British Journal of Cancer · 1998 · 42 citations · Full text

Medicine, Oncology, Chemotherapy +12

345 A multicenter, randomized study of two schedules of paclitaxel (PTX) in patients with advanced breast cancer (ABC)

Tamar Peretz, Aarón Sulkes, P. Chollet et al. · European Journal of Cancer · 1995 · 39 citations

Medicine, Oncology, Pharmacology +10